The TMJ Patient-Led RoundTable Meeting Series: TMJ Patients at Critical Crossroads

Our goal is to provide an update on the current status of Temporomandibular Disorder (TMD) initiatives, identify opportunities and barriers to advancing TMD research, education, and care. We highly value the input and participation of TMD patients in this meeting and ensure their voices are heard. Together, we will propose solutions to the barriers and make recommendations on how to implement these solutions, ultimately advancing the health of TMD patients and improving their care. Join us for the TMJ Patient-Led RoundTable Meeting.

Part 1 - Tuesday, September 12, 2023, 11:00 am to 2:30 p.m. EDT (virtual) Temporomandibular Disorders (TMD) at a Crossroads | Science, Patient Care and Education

Presentations

Recordings:

• Day 1 Part 1
• Day 1 Part 2
• Day 1 Part 3

11:00 – 11:05 a.m. ET | The TMJ Association

• Introduction to Meeting – John Kusiak, PhD, The TMJ Association

11:05 – 11:30 a.m. | Patient Concerns and Needs - Terrie Cowley, The TMJ Association (Session Chair)

• Lisa Schmidt, TMJ Patient Advocates

11:30 – 12:00 p.m. | Regulatory Perspectives and TMD Initiatives

TMD Regulatory Issues – Malvina Eydelman, MD, Center for Devices and Radiological Health, Food and Drug Administration and Srinivas Nandkumar, PhD, Center for Devices and Radiological Health, Food and Drug Administration

• TMD CRN as Critical Piece of Evidence Infrastructure – Danica Marinac-Dabic, MD, PhD, MMSc, FISPE, Center for Devices and Radiological Health, Food and Drug Administration
• Common Data Elements – Marti Velezis, MPH, Coordinated Registry Network Architecture Task Force, MDEpiNet and Laura Gressler, PhD, University of Arkansas for Medical Sciences 
• Patient Reported Outcome Measures – Fraser Bocell, MEd, PhD, Center for Devices and Radiological Health, Food and Drug Administration and Michelle Reardon and Lisa Schmidt, TMJ Patient Advocates

12:00 – 12:15 p.m. | Discussion – Greg Pappas, MD, PhD, Center for Biologic Evaluation and Research, Food and Drug Administration (Session Chair)

• Art Sedrakyan, MD, PhD, Weill Cornell Medicine
• Vahan Simonyan, MD, PhD, DNA HIVE

12:15 – 12:25 p.m. | Break

12:25 – 12:55 p.m. | NIH Highlights of TMD and Musculoskeletal Science

• NIH Supported TMD Research – Melissa Ghim, PhD, National Institute of Dental and Craniofacial Research
• BACPAC and REJOIN – Robert Carter, MD, National Institute of Arthritis and Musculoskeletal and Skin Diseases

12:55– 1:10 p.m. | Current State of Temporomandibular (TM) Joint Surgery

• State of TM Joint Surgery – Gary Bouloux, DDS, MD, Emory University
• Antibody Research - Vincent DiFabio, DDS, University of Maryland

1:10 – 1:50 p.m. | Bioengineering of the Temporomandibular Joint and Disc

• Overview of the TM Joint from an Orthopedic Perspective – Louis Mercuri, DDS, MD, Rush University Medical Center
• Comparing the TM Joint to the Knee Joint and Tissue Engineering of TMJ Disc – Kyriacos Athanasiou, PhD, University of California, Irvine
• Challenges and Opportunities – Alejandro Almarza, PhD, University of Pittsburgh

1:50 – 2:05 | Discussion – Kyriacos Athanasiou, PhD, University of California, Irvine (Session Chair)

• Alejandro Almarza, PhD, University of Pittsburgh
• Hai Yao, PhD, Clemson University/Medical University of South Carolina
• Ryan Donahue, PhD, University of California, Irvine
• Eric Granquist, DMD, MD, University of Pennsylvania
• Lisa Schmidt, TMJ Patient Advocate

2:05 – 2:25 p.m. | | National Institute of Dental and Craniofacial Research Initiatives

• TMD IMPACT Success Criteria – Rena D’Souza, DDS, MS, PhD, National Institute of Dental and Craniofacial Research

2:25 – 2:30 p.m. | Mini- Wrap-Up and Introduction of Day 2

• Terrie Cowley, The TMJ Association and Danica Marinac-Dabic, MD, PhD, MMSc, FISPE, Center for Devices and Radiological Health, Food and Drug Administration